Mayo Clinic Talks COVID-19 Miniseries Episode 58: Mayo Clinic Q&A - #AskTheMayoMom about COVID-19 and School Children
|Around the world, COVID-19 vaccinations are underway, but only in adults. Pfizer's vaccine has been authorized for ages 16 and up, while Moderna's vaccine is currently authorized for ages 18 and up. Vaccines are generally tested in adults first to ensure they are safe for pediatric trials. Both Pfizer and Moderna now have clinical trials underway to study the safety and effectiveness of COVID-19 vaccines in children. |
This edition of the Mayo Clinic Q&A podcast features an #AskMayoMom episode hosted by Dr. Angela Mattke, a pediatrician at Mayo Clinic Children's Center. Joining Dr. Mattke to discuss COVID-19, vaccines and children are Dr. Nipunie Rajapakse, a Mayo Clinic pediatric infectious diseases physician, and Dr. Emily Levy, a Mayo Clinic pediatric critical care and infectious diseases expert. Dr. Levy also discusses multisystem inflammatory syndrome in children, also known as MIS-C.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
This course is intended for primary care providers: physicians, nurse practitioners, and physician assistants
Upon completion of the Mayo Clinic Talks Podcast course, learners should be able to:
- Describe the current treatment recommendations for patients with hyperlipidemia.
- List the various categories of hypertension.
- Describe the current pharmacologic treatment available for patients with osteoporosis.
Participation in this Mayo Clinic online course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Attendance